Abridge secures strategic investment from Eli Lilly and partners with Nvidia on AI foundation model
read at STAT ↗DealPositive
Abridge, a health‑tech AI company, announced two new deals on Thursday in New York.
Eli Lilly will make a strategic investment in Abridge, signaling pharma interest in AI scribes that document visits and guide clinicians.
Abridge also entered a collaboration with chipmaker Nvidia to develop the first foundation model built specifically for healthcare applications.
The company showcased updated platform features that aim to streamline billing and support doctors throughout patient encounters.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Abridge inks deals with Nvidia and Lilly”
read at STAT ↗519 words · retrieved Jun 11
comments(0)
5-min edit window · permanent after that